| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2024 | Jun 11, 2024 | Celldex Therapeutics, Inc. | SVP, CHIEF MEDICAL OFFICER | Sell | 17.5 | -45,000 | -95.51% | ✗ | $1.6M |
| Aug 17, 2022 | Aug 19, 2022 | Celldex Therapeutics, Inc. | SVP, CHIEF MEDICAL OFFICER | Sell | 20.0 | -19,000 | -89.98% | ✗ | $708.7K |
| Nov 12, 2021 | Nov 16, 2021 | Celldex Therapeutics, Inc. | SVP, Chief Medical Officer | Sell | 22.5 | -4,600 | -68.50% | ✗ | $197.5K |
| Jun 11, 2020 | Jun 12, 2020 | Celldex Therapeutics, Inc. | SVP, Chief Medical Officer | Buy | 91.3 | +2,115 | 100.00% | ✗ | $10K |